Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state

Robert J Rounbehler1, Mohammad Fallahi, Chunying Yang

  • 1Department of Cancer Biology, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA.

Cell
|August 7, 2012
PubMed

Insights

Myc oncoprotein affects gene expression by regulating mRNA turnover through AU-binding proteins (AUBPs). Suppressing Tristetraprolin (TTP) is key to Myc-driven cancers, with TTP acting as a tumor suppressor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Myc oncoproteins influence gene transcription, but a significant portion of Myc-regulated genes involves post-transcriptional mechanisms.
  • mRNA turnover is modulated by AU-binding proteins (AUBPs) that interact with AU-rich elements (AREs) in transcripts.
  • Understanding Myc's impact on AUBPs and ARE-containing (ARED) genes is crucial for deciphering its role in tumorigenesis.

Purpose of the Study:

  • To investigate how Myc oncoproteins regulate mRNA turnover via AUBPs and ARED genes.
  • To determine the role of Tristetraprolin (TTP/ZFP36), an AUBP, in Myc-driven lymphomagenesis.
  • To elucidate the mechanism by which Myc influences TTP expression and its consequences in cancer.

Main Methods:

  • Analysis of precancerous and malignant Myc-expressing B cells.
  • Assessment of Myc's direct transcriptional regulation of TTP and other ARED genes.
  • Evaluation of TTP's function in Myc-induced lymphomagenesis and cancer maintenance.

Main Results:

  • Myc regulates hundreds of ARED genes and specific AUBPs in B cells.
  • Myc directly suppresses the transcription of the mRNA-destabilizing AUBP, Tristetraprolin (TTP).
  • TTP suppression is a hallmark of MYC-involved cancers, and its restoration inhibits lymphomagenesis, indicating TTP acts as a tumor suppressor.

Conclusions:

  • Myc utilizes AUBPs, particularly TTP, to control ARED genes involved in tumorigenesis.
  • The suppression of TTP by Myc is a critical circuit in B lymphopoiesis and IL7 signaling, and its dysregulation is selected for in malignancy.
  • Targeting the Myc-TTP axis offers potential therapeutic strategies for MYC-driven cancers.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K